Brooklyn Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Brooklyn Investment Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46M	Buy	1,889 +663	+54%	+$508K	0.05%	390
2025 Q4	$957K	Buy	1,226 +810	+195%	+$550K	0.04%	369
2025 Q3	$216K	Buy	416 +9	+2%	+$5.09K	0.03%	555
2025 Q2	$213K	Sell	407 -103	-20%	-$57.5K	0.03%	579
2025 Q1	$323K	Buy	510 +116	+29%	+$79.8K	0.07%	249
2024 Q4	$281K	Sell	394 -126	-24%	-$106K	0.08%	201
2024 Q3	$547K	Buy	520 +36	+7%	+$40.1K	0.18%	104
2024 Q2	$469K	Hold	484	–	–	0.2%	109
2024 Q1	$469K	Sell	484 -14	-3%	-$13.3K	0.2%	109
2023 Q4	$437K	Buy	+498	New	+$410K	0.21%	111

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Brooklyn Investment Group's REGN Position: Q1 2026 in Review

Brooklyn Investment Group increased its Regeneron Pharmaceuticals (REGN) stake by 54% in Q1 2026, buying an estimated $508K and bringing the position to 1,889 shares worth $1.46M. The position accounts for 0.05% of the portfolio, ranked #390.

Brooklyn Investment Group first reported a position in REGN in Q4 2023 and has held it in 10 quarters since. 1,400 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Brooklyn Investment Group held 1,889 shares of Regeneron Pharmaceuticals worth $1.46M as of Q1 2026.
Brooklyn Investment Group bought 663 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $508K.
Regeneron Pharmaceuticals made up 0.05% of Brooklyn Investment Group's portfolio in Q1 2026, its #390 holding.
Brooklyn Investment Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
1,400 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.